Schuth Alexander O.'s Form 4/A amendment
AmendedDenali Therapeutics Inc. (DNLI) · filed Jan 9, 2023
- Accession no.
- 0001209191-23-002545
- Filed
- Jan 9, 2023
- Trade date
- Jan 4, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Jan 5, 2023
This filing lists 1 non-derivative transaction. It carries over 2 transactions from the original filing that it did not restate. Open-market sales total $83.6K. It was filed 5 days after the trade.
This amendment restates part of 0001209191-23-002181 (filed Jan 5, 2023). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schuth Alexander O.CIK 0001724311 | Officer (COFO and Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2023 | Common Stock | SSaleDisposed | −2,912 | $28.70F2 | −$83,574.4 | 492,309 | Indirect |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001209191-23-002181 (filed Jan 5, 2023).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2023 | Common Stock | AGrant or awardAcquired | +41,120 | $0.00 | $0 | 157,578 | Direct |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2023 | Common Stock | AGrant or awardAcquired | +123,360 | $0.00 | $0 | 123,360 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs.
- F2
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.48 to $28.96 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 7,750 RSUs held by the Reporting Person.
- F4
The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.
Remarks
This amended Form 4 is filed because 2,912 shares were sold by The Schuth Family Trust, not by the Reporting Person.